Intimation of Earnings Conference Call for the quarter ended 31st December, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals has informed the stock exchanges that it will host an earnings conference call on Thursday, 12th February 2026 at 12:00 PM, after announcing its financial results for the quarter and nine months ended 31st December 2025 (Q3 FY26). The call is being organized along with Kirin Advisors, and Managing Director Mr. Fredun Medhora will represent the management. Investors and analysts can join the call through a Diamond Pass registration link or via the universal dial-in numbers provided.
This is a routine disclosure to inform investors about the upcoming earnings call. It does not contain any financial numbers or business update by itself, but signals that Q3 FY26 results are imminent and the management is willing to engage with investors and analysts.